FTC targets another CBD marketer for unsubstantiated disease claims A marketer of CBD products has agreed in a Federal Trade Commission administrative proceeding to cease making unsubstantiated disease treatment claims and pay more than $30,000 in consumer redress.
The case brought against Arizona-based Kushly Industries LLC (Kushly) and the company’s sole officer Cody Alt is the seventh such enforcement brought by FTC against a CBD/hemp firm, according to Daniel Kaufman acting director of the FTC’s Bureau of Consumer Protection.
“There may be some benefits of CBD, but there’s no proof that it can treat the serious health conditions in Kushly’s advertising, such as Parkinson’s, multiple sclerosis, or cancer,” Kaufman said.
FTC targets another CBD marketer for unsubstantiated disease claims nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.
The Federal Trade Commission said Monday that Arizona-based CBD company Kushly and its owner will pay $30,000 in consumer redress after an investigation revealed their deceptive marketing practices and unsubstantiated claims that CBD products could help treat Parkinson's disease, Alzheimer's disease, cancer, multiple sclerosis, hypertension and other serious ailments.
FTC and CBD: Latest case challenges unproven health claims ftc.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ftc.gov Daily Mail and Mail on Sunday newspapers.
FTC Continues Crackdown On CBD Sellers Cure-All Claims law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.